III. Prevalence
In a study, 24% of a group of sufferers of malignancy had severe depression, 18% had moderate depression. Depressive symptoms not meeting criteria for major depression were present in another 14%. Important predictors were greater degree of physical debility, other negative life events and poor social support (Bukberg, 1994) .
Estimated frequency of depressive disorder in various subgroups of sufferers of malignancy, in a systematic review, was as follows: outpatients-5% to 16%; admitted patients-4 to 14%; mixed sample including both patients receiving treatment on outpatient basis as well as those admitted-4 to 11% and palliative care-7 to 49%. Lower prevalence was found by studies which employed specialist interviewers (clinical psychologists and psychiatrists) (Walker, 2013) .
In a study on women with newly diagnosed carcinoma breast, the following findings were reported. Clinically significant distress was present in 41% of the subjects. Major depression was present in 11% (60% of whom had moderately severe to severe depression) and posttraumatic stress disorder was present in 10% subjects. These emotional symptoms had a marked impact on the functioning of the patients. Though 56% of the depressed patients were already on psychotropic medications, they still did not remit. (Hegel, 2006) Psychiatric referral patterns at two Japanese cancer hospitals showed that the most commonly referred were patients with lung cancer (19%), followed by carcinoma breast (13%) and malignancy of the head and neck (10%). More than 50% of the sufferers had cancer recurrence or metastasis, pain was present in 60%. The most frequent reasons for psychiatric referral were assessment by mental health professional (35%), insomnia (19%), fear/anxiety (18%), and depressive disorders (18%). Adjustment disorder (34%), acute confusional state (17%) and major depressive disorder (14%) were the most common psychiatric diagnoses. (Akechi, 2001) Adjustment disorder or major depression was seen in about 17% of the subjects in one study among recently found out sufferers of malignancy of head and neck. Nicotine dependence was present in about 33%. Psychological distress had significant association with stage of cancer and living alone. (Kugaya, 2000) DIFFERING VIEW: A study looked for anxiety and depression in patients with prostate or other urogenital cancers. The highest anxiety mean scores were recorded at the start of the hospital stay (i.e. in stage T1). From stage T2 to T4, the prevalence of anxiety was similar to that of the general population, and even less than that found in cardiac patients. Lower prevalence of depression was found compared to the general population. Higher psychological distress was found in those who were younger, and in those who were receiving radio-or chemotherapy. Based on their findings, the authors concluded that professional psychiatric help was not required by most prostate cancer patients and that some patients may benefit from such help, especially at the beginning of the hospital stay. (Hinz, 2009) Adjustment disorder with depressed mood or depressive disorder is found in about 25% of hospitalized cancer patients. Important predictors are mood disorder or alcoholism in the past, cancer stage, presence of pain, medications which produce depressive symptoms, concurrent illnesses which lead to depressive symptoms (Massie MJ, 1990) .
Another study reported that emotional distress that was clinically noteworthy (Hospital Anxiety and Depression score ≥15) was present in about 1/4th of the study sample of 3071 patients. Important determinants were age less than 65 yrs, female gender, and type of cancer and extent of disease (Strong, 2007) .
A study done in a tertiary care hospital among gynaecological oncology outpatients found that nearly 26% had depression and 17% had anxiety (Mendonsa and Appaya, 2010) .
In an outpatient oncology setting, about 14% were found to have depression. They found that the existing health care system had managed to identify and treat only 14% of the interviewed depressed patients and they highlighted the need for suitable screening tools (Berard, 1998) .
It is hard to assess mood disorder when a cancer sufferer is faced with recurring threats to existence, receiving treatments for malignancy, has fatigue or aches. Many studies since the 1960s have found the prevalence of depression between 0-38% and that of depression spectrum syndromes as being 0-58%. This wide variance is due to different conceptualisations of depression, different defining criteria for depression, different methodological approaches in measuring depression and different populations being studied. Cancers with highest depression prevalence were upper digestive tract (22-57%), pancreas (33-50%), mammary (1.5-46%) and pulmonary (11-44%) (Massie, 2004) .
In another study, 40% of carcinoma lung sufferers had anxiety and 25% were depressed, and this was found to be equal among hospitalized patients as well as those attending the outpatient clinic. (Du-Quiton, 2010).
Effect of depression on cancer
Most studied cancers in this regard are malignant melanoma, CA lung, and renal carcinoma and CA breast. The mortality risk is raised when depressive symptoms co-occur with malignancy (Onitilo, A study of psychiatric comparability in subjects with malignancy . The 1 year and 3 year case fatality rate was increased significantly by the occurrence of depression in sufferers of hematologic malignancy following stem cell transplantation (Prieto, 2005) . In sufferers of lung malignancy, reduced survival times are foretold by emotional distress and depressive coping style (Faller, 1999) .
How depression affects cancer prognosis: 1.
As a direct neuroimmunologic consequence 2.
Depression may lead to poorer compliance to the treatment given for cancer
The Minnesota Multiphasic Personality Inventory (MMPI) clearly differentiates the psychological distinction among the two extreme set of cancer sufferers-those with rapidly progressing disease and those with a far longer expectancy (Blumberg, 1954) .
Psychosocial factors like social support, stress, emotional expression, depression and personality have been found to influence the incidence and progression of cancer. This relationship has been proposed to be mediated by mechanisms such as changes in diet, exercise, and circadian rhythms; differences in treatment received; and endocrinologic and neuroimmunologic physiological changes (Spiegel and Kato, 1996) .
There is a profound stimulating effect of stress on the growth rate of an established cancer (Blumberg, 1954) . The cell-mediated immunity, which protects an individual against cancer, may be affected by depression. The impaired host defense mechanisms may pave the way for neoplastic cells to proliferate and spread out of control. Increased IL-6 plasma levels were associated with MDD in cancer patients (Musselman, 2001; Jehn, 2006) . Social support is protective against IL-6 elevation in patients with advanced malignancy of the ovary & IL-6 appears to be a marker of health related quality of life (Constanzo, 2005) . Therefore, IL-6 is a biomarker of depressive disorder in sufferers of malignancy.
In case of severe depressive disorder preceding malignancy, the depressive illness may present an additional risk (Kronfol, 1982; Linn, 1982) .
The course of cancer and treatment compliance is also severely impacted upon by depressive disorders (Pasquini and Biondi, 2007) .
Depression And Cancer Mortality:
Studies have found that the diagnosis of depression and more severity predicted increased mortality in cancer patients (Pinquart and Duberstein, 2010) . Mental anguish was a forerunner of death due to malignancy, particularly in pulmonary malignancy (Hamer, 2009 ).
In one study among patients with advanced non-small cell lung cancer (NSCLC), the median survival time in the depressed group was significantly shorter than that of the non-depressed group. The mortality risk in the group with depression was twice that seen in the group without depression. The result shows that depression at the starting stage of cancer therapy predicts decreased survival in sufferers of advanced non-small cell lung cancer (Chen, 2011) .
Depressive disorder foretold reduced survival in sufferers of recently detected non-small cell lung cancer in metastatic phase. In spite of the fact that early palliative care (EPC) was linked with more reduction in depressive symptomatology at 12 weeks, the study findings did not support the premise that the survival benefit which was seen to be due to EPC was a consequence of the treatment of depression (Pirl, 2012) . DISSENTERS: A nationwide Danish cohort study, carried out over a period of 24 years, found that their findings did not support the premise that depressive disorder separately raises cancer possibility, but they emphasized the detrimental effects of depressive symptomatology on aspects of day-to-day life (Dalton, 2002) . Another study found no evidence of an increased risk of cancer in patients with depression and/or anxiety for over a decade (Friedman, 1990) .
Depressive disorder is linked to inferior quality of life, suppression of immune reaction and reduced survival in sufferers of malignancy (Williams and Dale, 2006) .
Relationship of various parameters to depression and anxiety in cancer Role of aging:
Growing old was associated with decreased anguish, decreased apprehension, and improved psychological quality of life. At the same time, growing old was linked to increased depression in these sufferers of malignancy ).
The frequency of anxiety and depression in sufferers of malignancy was notably influenced by age upto 40 years (Jadoon, 2010) .
Depression frequently manifests in a different way both in sufferers of malignancy as well as in old age. Hence a tailored and customized way of evaluation should be used when making a diagnosis and managing these persons Compared to any other psychopathological variable studied; disease has a greater independent role (Fafouti, 2010) .
In a study, the only variables found to affect distress and depression were higher socioeconomic status and female gender respectively (Pandey, 2006) .
Effect of being aware of diagnosis:
Psychological distress was higher in those who knew their cancer diagnosis (Tavoli, 2007) . Mental and emotional well-being depends very much upon the issues regarding culture and the manner in which information is communicated to sufferers of malignancy (Chowdhury, 2011) .
Regardless of the type or phase of cancer, it may be important to recognize and manage somatic symptoms in order to achieve improved quality of life and functioning (Kroenke, 2010) .
Patients detected to have an anxiety disorder were more expected to be of female gender, of lesser age, and have a poorer status of physical performance (Spencer, 2010) .
Those patients with a past history of alcohol abuse/dependence or mood disorder, later stages of malignancy, pain under poor control, and therapy using drugs or concurrent diseases that cause depression are at utmost risk of developing depressive disorder (Massie, 1990) .
The chances of elevated scores of the Center for Epidemiologic Studies-Depression Scale (CES-D) were notably decreased in patients aged more than 50 years in comparison with those whose age was less than or equal to 50 years. The score was also lesser in patients with greater levels of social support and in patients in employment. Men were more to be expected to have depressive disorder indicated by higher CES-D scores. Awareness of sociodemographic features will help the physician to identify those persons who have an increased risk of associated depressive symptomatology (Reisine, 2005) .
Nearly 33% of long-term survivors of malignancy (5 years +) go on to harbour fears of recurrence, fears of developing yet another malignancy, and fears that some of their symptoms may be due to malignancy. Health anxieties related to malignancy are an important predictor of both anxiety and depression. The largely unfailing predictor of mental anguish is optimistic/pessimistic disposition, with lesser malignancy-associated health anxieties, and lesser depression and anxiety, in persons with dispositional optimism. All said and done, for most of them, physical or psychological quality of life is not radically compromised (Deimling, 2006) .
Quality of life is predicted by 4 major variables: contentment with support of family doctor, malignancy severity, sufferer's gender, and malignancy type. Mental state was predicted by 3 main factors: anorexia, support of family doctor, sufferer's gender (Mathieson, 1996) .
HADS depression score was significantly correlated with fatigue, nausea, sleep disturbances, distress, and memory, loss of appetite, drowsiness, dry mouth and sadness (Arun, 2011) .
In one study, long term survivors of NSCLC were studied regarding their quality of life. It was found that hopeful survivors formed the majority (71%), and the experience of malignancy was seen as leading to constructive existential changes by 50% of the survivors. Sixty percent had more than one condition showing that co-morbidity was frequent; a CES-D score of more than 16 was found in 22% indicating distressed mood. 76% had been smoking previously. A prospective target for intervention is comprised of the predictors of poorer quality of life which are robustly related to distressed mood (Sarna, 2002) .
Among non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) sufferers, sufferers with SCLC had thrice higher frequency of depressive disorder than those with NSCLC. The most vital risk factor was impairment of function; for every increase on the functional impairment score, depressive symptoms rose by 41 percent. Major independent predictors were load of somatic symptoms prior to treatment, fatigue and performance status rated by physician. Histological subtype was not an independent predictor (Hopwood, 2000) .
The most depressed and anxious sufferers of lung malignancy are those who have repeated and long duration waking periods at night and repeated and long duration sedentary periods during day. The anxiety and/or depression scores are directly proportional to the severity of disruption of the circadian rhythm (DuQuiton, 2010).
Depressive disorder was linked to female sex and performance status being low. 1/3 rd of sufferers of newly detected non-small cell lung cancer had anxiety and depression. This was linked to reduced score on health-related quality of life questionnaires, and compliance to therapy and bad prognosis were independently linked to depression (Arrieta, 2013) .
Depressive disorder is frequent and persistent in sufferers of pulmonary malignancy, more so in those with more relentless symptoms or limitation of function. Therefore, palliation must include the crucial element of screening for psychological problems and managing them appropriately.
Role of personality and coping styles
More cognitive distortions and maladaptive assumptions were present in the group with depressive symptomatology. The prime coping mechanism which was employed by subjects in the group A study of psychiatric comparability in subjects with malignancy DOI: 10.9790/0853-1509025077 www.iosrjournals.org 55 | Page without depressive symptomatology was fighting spirit, while the mechanisms used to cope in the group with depressive symptomatology were hopelessness/helplessness, being preoccupied / being worried and fatalistic coping style (Alcalar, 2012) . Existing research suggests that malignancy sufferers' adjustment may be constructively impacted upon by coping through spiritual and religious means (Jenkins, 1995) .
It is important to survey the patients' personalities in order to grasp their QOL accurately (Nakada, 1996) .
Mental factors which have strong association with increased depressive risk are personality characteristics like neuroticism, and coping approaches such as anxious preoccupation, hopelessness / helplessness and low fighting spirit. Depressive symptomatology was robustly associated with temperamental traits and mechanisms employed to cope, and employing tools for screening to recognise these variables might be helpful for planning preventive (Shimizu, 2012) .
Effect of cancer stigma
Sufferers who felt or experienced the stigma of malignancy were 2.5 times more expected to have depressive disorder than sufferers with optimistic disposition. In spite of quantum leaps made in the field of medicine and greater survival rates, malignancy survivors still felt stigmas about malignancy, and it was notably linked to depressive symptomatology. These results stress upon the requirement for the medical fraternity and health care providers to give more notice to stigma about malignancy which sufferers may be expected to face during therapy (Cho, 2013) .
Anxiety and depression screening in malignancy
Many studies till date which have examined the existence of anxiety and depression in sufferers of malignancy have used the Hospital Anxiety and Depression Scale (HADS) (Moorey, 1991; Kugaya, 2000) . The HADS is an easy to administer, self-rated instrument and is efficient in screening for depressive and anxious symptomatology, even in early stages of malignancy (Berard, 2001 ). It has been found that the HADS, along with the Impact of Event Scale's intrusion subscale, can be useful to detect chances of tardy development of depressive and anxious symptomatology in sufferers of malignancy (Nordin, 1999 ).
Yet another screening instrument found to be adequate for use in patients with cancer is the Beck Depression Inventory -II (BDI-II) (Warmenhoven, 2011)
Prediction of depression and anxiety following detection of malignancy
An investigation was done to inspect the likelihood of predicting depressive and anxiety disorders 6 months after detection of malignancy, based on scores of depressive and anxious symptomatology, mechanisms employed to cope and subjective anguish associated with the detection of cancer. Patient anxiety and depression close to the detection explained nearly 35% of the variation in depression and anxiety symptoms seen after 6 months. For finding out sufferers who are likely to develop tardy depression and anxiety, the Impact of Events Scale-Intrusion Subscale and the Hospital Anxiety and Depression Scale may be useful tools (Nordin, 1999 ).
Yet another study found that age less than 65 years, being employed or not, family support, and several symptoms due to malignancy or treatment independently predicted depressive disorder (Agarwal, 2010) .
Gender, race, co-morbid conditions, physical functioning, social functioning, and symptoms were important predictors of depression. Both greater number of symptoms and greater limitation of functional performance in somatic and social domains were associated with increase in symptoms of depression (Kurtz, 2002) .
Functional performance in the emotional domain is a vital predictor of the need for social support. Women are emotionally more affected than men and need more psychosocial support (Ernstmann, 2009 ).
More severe symptoms of depression, being of young age and being single-all these increase the chances for sufferers of metastatic malignancy of being referred for psychosocial supportive care (Ellis, 2009 ).
Feminine sex was linked to the existence of depressive and anxious symptomatology. Lesser tumour grade on the WHO classification of grade of malignancy, academic accomplishment being lower, and past history of mental disorder were significant predictors of depressive and anxious symptomatology. Depressive disorder alone was significantly linked to relationship status and history of current/past physical disease (Arnold, 2008) .
Effects of cancer on depression
Epidermal Growth Factor Receptor mutations were linked to reduced severity of depressive disorder and decreased probabilities of depression in sufferers of non-small cell lung cancer in metastatic stage. This was found out on the basis of screening for affective symptoms done prior to obtaining the genotyping findings (Pirl, 2011) . Affective disorders are promoted by the physiologic substrate afforded by inflammation (Raison & Miller, 2003) . Features of cytokine induced sickness syndrome in cancer include fatigue, loss of appetite & weight, cognitive disturbances, decreased motor activity and libido.
Links among state of nutrition, systemic inflammation, and subjective mental suffering are evidence of their shared fundamental pathophysiology and go on to impress upon the need for an anti-cachectic approach which is holistic (Giannousi, 2012) .
Effects of chemotherapy
In a study, 13.7% patients who were undergoing chemotherapy experienced depression. Important predictors were education level and symptoms like pain, insomnia, nausea, anorexia and fatigue .
Chemotherapy is associated with many adverse effects which negatively affect the quality of life of sufferers of malignancy of the breast. Similar is the case with adjuvant hormonal therapies (Montazeri, 2008) .
In a study among patients undergoing chemotherapy, anxiety was found in about 15% and depression in about 16% subjects. They found that high social status influenced presence of distress and female gender influenced the prevalence of depression (Pandey, 2006) .
The anxiety state is significantly higher in patients treated with cytotoxic drugs than in operated and increased during the time of treatment. In patients treated with cytotoxic drugs, anxiety as a feature, increased in the course of treatment, and in patients treated surgically it remained stable (Nalepa, 1996).
Li and colleagues (2012) found in their study that during chemotherapy, the patients had significant anxiety.
Effects of radiotherapy
Psychological distress was found to be highly prevalent (30% of cases) in persons receiving radiotherapy for malignancy of the head and neck (Bjordal, 1995) This is true even before beginning treatment and it increases significantly during treatment (Chen, 2009 ).
In another study, 33% of patients who had completed a course of radiotherapy had depression (LloydWilliams, 1994).
Patients' views about radiotherapy: Most patients believed that radiation is inherently damaging and carcinogenic. They thought that it was bad news if they required radiotherapy. It was seen as curative by few. Post treatment interviews showed more depression and anxiety than pre treatment interviews. This meant that the procedure was a stressful one. However, it is ironic that the concepts of very serious adverse effects and futility of this treatment among both doctors and lay people are largely false (Peck and Boland, 1972) .
A study looked for anxiety and depression in patients with prostate or other urogenital cancers. Higher psychological distress was found in those were receiving radiotherapy (Hinz, 2009 ).
IV. Aim And Hypothesis

Objectives
Primary objective-To find the prevalence of depression and anxiety in lung cancer patients in a tertiary hospital inpatient population. Secondary Objective(s)-1. To find the risk factors for depression and anxiety in lung cancer patients. 2. To determine the extent to which depression and anxiety can be predicted on the basis of measures of subjective distress and social support.
V. Materials And Methods
Study centre
We recruited the participants for the study from the inpatients admitted in the Dept. of Medical Oncology, Rajiv Gandhi Govt. General Hospital, Chennai.
All the study participants were of different stages of lung cancer who were planned for chemotherapy or already undergoing it.
Patient selection
We interviewed the patients by the bedside during their inpatient admission. We informed them about the nature of the assessment-to elicit psychological distress-being done as a part of a research study and obtained their informed consent to proceed with the assessment.
Inclusion criteria
All patients diagnosed with lung cancer irrespective of stage or grade Exclusion criteria a. Patients not willing to participate b. Patients already diagnosed as having any mental illness before the onset of cancer c. Patients who were not physically fit enough to complete the study d. Patients with severe cognitive impairment screened by MMSE
Screening
We used the Hospital Anxiety and Depression Scale (HADS) to screen the presence of anxiety and/or depression. A score of 8 or above on the anxiety and/or depression subscales denoted case status.
Sample size
We conducted the data collection over a period of three months. The sample size was 93.
Assessment of patients
We made two types of assessments: 1. For those scoring 8 or more on the HADS subscales, all the questionnaires mentioned below were administered. 2. For those scoring less than 8 on the HADS subscales, all the questionnaires mentioned below were administered, except for the Hamilton Depression Rating Scale (HAM-D/HDRS) and the Hamilton Anxiety Rating Scale (HAM-A).
Sociodemographic data
We recorded the patients' socio-demographic variables and illness variables on a proforma specially designed for the study (Appendix I).
Phase of illness
Phase of illness was classified as: phase 1-newly diagnosed persons, phase 2-persons in first remission, phase 3-persons following the development of a second primary lesion without metastasis, and phase 4-persons with metastatic disease (Agarwal, 2010 (Sheehan, 1996) . In patients suffering from cancer, the impact of somatic symptom burden on disability and healthcare use can be quantified by using the Sheehan Disability Scale (SDS). This is important because somatic symptoms have to be recognized and managed in order to improve quality of life and functional status of these patients (Kroenke et al, 2010 
VI. Results
Ninety three consecutive cases were included in the study to assess the prevalence of depressive and anxiety symptoms in the group of inpatients admitted in the Medical Oncology Department, Rajiv Gandhi Government General Hospital, Chennai for non-small cell lung cancers (NSCLCs) of various stages.
The breakup of the sample consisted of 43 patients diagnosed as cases when the cut-off score of HADS more than or equal to 8 was taken. A total of 93 patients were screened to obtain this sample with the rest 50 being controls.
Those scoring just below the cut-off score of 8 were further evaluated for the presence of depression and/or anxiety using the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID). Of that group of 50 patients none was found to fulfil the criteria for a diagnosis of depression and/or anxiety. This was done so as not to miss out any cases screened by the HADS.
Sample demographics
The demographic profiles of the sample are given below:
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Chart 1
The two groups did not differ significantly in gender distribution. The mean age of the sample was 52.72 years with a standard deviation of 12.024 years.
Chart 2: Age distribution
The median age of the sample was 52 years and the age distribution followed normal distribution.
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Chart 3: Age distribution among cases and controls
Controls
The two groups did not differ significantly in age distribution. Case and control group did not differ significantly in terms of place of residence.
Cases
Chart 4:
Most of the subjects in both the groups resided in rural areas. Case and control group did not differ significantly in terms of educational qualification.
Chart 5:
Most of the subjects in both groups had never attended school.
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Chart 6: Occupation
Controls
Unskilled work was the most common occupation in both groups.
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Chart 7:
Most of the subjects in both the groups were married. The two groups did not differ significantly in terms of family type.
A study of psychiatric comparability in subjects with malignancy 
Controls
Cases 1=staying alone, 2=nuclear, 3=extended, 4=joint, Nuclear family was most common in both case and control groups. Tamil was the most common language spoken in both groups. Hinduism was the most common religion practised among both groups. Table 11 : Mean time since diagnosis
Cases
The mean time since diagnosis in the control group was 24 months whereas in the case group it was 16 months. There was no significant difference between the two groups in terms of phase of illness. Most of the subjects in the case group were in phase 4 whereas most in the control group were in phase 2 of illness. The two groups did not differ significantly with respect to nicotine dependence.
Independent samples T-Test to compare the mean value between groups
Chart 12:
Nicotine dependence pattern was similar between the case and control groups.
Chart 13:
The two groups did not differ significantly in terms of Karnofsky performance status score.
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Chart 15:
The Mean HADS Depression Score was significantly high in the case group compared to the control group. There was significant difference between the two groups in terms of HAM-A score. Mild anxiety was most common (41.9%) followed by very severe anxiety (30.2%) in the case group.
Chart 17:
The mean HAM-A score in the case group was 21 There was significant difference between the two groups in terms of HAM-D score. Very severe depression was most common (62.8%) followed by moderate depression (14%) in the case group
Chart 18:
The mean HAM-D score in the case group was 23.8 The two groups did not differ significantly in terms of both Number and Satisfaction subscales of the Social Support Questionnaire.
Chart 20:
Significantly higher stressful life events scores were observed in the case group compared to the control group.
Chart 21:
Significantly higher Total WHOQOL-BREF scores were observed in the case group compared to the control group. 
VII. Discussion
The objective of the study was to evaluate the association of certain sociodemographic and illness related factors with depression and anxiety in a group of patients with lung cancer. The factors to be studied were selected after reviewing earlier studies which indicated some variables to be more frequently linked to psychological distress in patients with cancer. These factors have been summarized by Holland (1993) .
Selection of the sample population for the study
The factors gender, age and phase of illness were all considered as variables in the study. Because cancer is a heterogenous condition we did not want to study all cancers, keeping type of cancer as a variable. This was so decided because the findings in one type of cancer can't be generalized to all other types of malignancy. Hence we decided to confine our study to the prevalence and predictors of depression and anxiety in patients with non-small cell lung cancer. This group of 93 consisted of the patients consecutively admitted in the Medical Oncology ward in Rajiv Gandhi Government General Hospital, Chennai during the specified period and more sample size couldn't be collected due to time constraint.
The patients were seen in a tertiary referral hospital setup. Most of them had been referred there with long duration of illness, after failed attempts at treatment or for more advanced therapy.
Prevalence of depression and anxiety
With respect to anxiety, 33 subjects (i.e. 35%) scored above 8 in HADS Anxiety subscale and hence were considered as cases. False negatives among the remaining 60 controls (i.e. 65%) were avoided by subjecting them to clinical interview using the SCID. The prevalence rate of 35% in the study is on the higher side compared to previous studies. Akechi et al (2001) found the prevalence of anxiety to be 18% in their study. Mendonsa and Appaya (2010) found the figure of 17%.
With respect to depression, 38 subjects (i.e. 41%) scored above 8 in HADS Depression subscale and hence were considered as cases. False negatives among the remaining 55 controls (i.e. 59%) were avoided by subjecting them to clinical interview using the SCID. The prevalence rate of 41% in the study is on the higher side compared to previous studies. Bukberg et al (1994) had found in their study 24% prevalence of severe depression and 18% prevalence of moderate depression. Hegel et al (2006) found depression in 11% of their study subjects. Akechi et al (2001) reported a figure of 14% in their study. Kugaya et al (2000) found out a prevalence of 17% in their study subjects. Massie MJ (1990) reported 25% prevalence in hospital admitted patients with cancer. Mendonsa and Appaya (2010) found out 26% frequency of depression in their study. A prevalence of 14% was reported in an outpatient oncology clinic by Berard et al (1998) . Many other previous studies on the prevalence of depression in lung cancer have placed the figure anywhere in the range of 11-44% (Massie, 2004) .
The high prevalence of anxiety and depression in this study could be due to the following reasons: 1. The criteria used included mild, moderate and severe forms of anxiety and depression. 2. Many of the subjects had recurrence after successful treatment. Recurrence has higher prevalence of depression compared to the primary therapy of terminal stage groups (Silberfarb, 1980) . Thus, it is evident that many high risk factors for depression and anxiety being inherent in the chosen sample could have led to the high prevalence rate. 3. The criteria didn't exclude somatic symptoms in the patients which was very high as found in the study. 4. The reactive element (? Adjustment disorder) couldn't be ruled out.
Illness related variables
The present study found an increased frequency of the most common symptoms seen in cancer patients i.e. anorexia, fatigue, sleep disturbance, in patients who had scored above the cut-off for being designated as cases. Although this could be expected because it could have been contributed by either depression or cancer or both, it is also possible that persons with underlying dysphoric mood may perceive more somatic symptoms (Endicott, 1984) . The study also revealed that phase of illness has a bearing upon being depressed or anxious. It has revealed that the advanced phase 4, with its attendant complications was significantly associated with depression and anxiety. This could probably be due to the fact that there is more physical disability in this phase compared to the phases 1 and 2.
Time since diagnosis
Mean time since diagnosis was found in our study to be 16 months in the case group compared to 24 months in the control group. Probably, the additional symptom burden of depression and/anxiety affected response to treatment and hence referral to tertiary care at an earlier time in these patients. DOI: 10.9790/0853-1509025077 www.iosrjournals.org 75 | Page 5. More than self-report scales, in-depth interviews, case studies and other qualitative methods of research would be valuable in exploring concepts and processes which are part of this domain. 6. There is a dearth of studies on depression and/anxiety in lung cancer patients which needs to be addressed in the future.
IX. Conclusion
1.
The prevalence of depression and anxiety in lung cancer patients in this tertiary hospital inpatient population was found to be 41% and 35% respectively. 2.
The major risk factors for depression and anxiety in lung cancer patients as found in the study were presence of concomitant life stressors, advanced cancer phase and higher disability. 3.
The observation of the association of some factors other than the illness requires interventions of psychosocial nature with all patients. Specifically, there is need to explore the personal meaning of cancer symptoms, of terminality, death and dependency from the individual and socio-cultural context of sufferers of malignancy. Efforts must be made to provide this help along with medical care to all patients. This necessitates close liaison between the fields of Psychiatry and Oncology leading to the flowering of the branch of Psycho-oncology.
